NIMI
NVO

Natixis Investment Managers International’s Novo Nordisk NVO Stock Holding History

Natixis Investment Managers International’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,926
Closed -$45K – 403
2018
Q3 		$45K Buy
1,926
+322
+20% +$7.86K ﹤0.01% 694
2018
Q2 		$37K Hold
1,604
– – ﹤0.01% 708
2018
Q1 		$40K Hold
1,604
– – ﹤0.01% 435
2017
Q4 		$43K Hold
1,604
– – ﹤0.01% 141
2017
Q3 		$39K Hold
1,604
– – ﹤0.01% 392
2017
Q2 		$34K Buy
+1,604
New +$32.4K ﹤0.01% 396

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Natixis Investment Managers International's NVO Position: Q4 2018 in Review

Natixis Investment Managers International sold out of Novo Nordisk (NVO) in Q4 2018, closing a stake of 1,926 shares — an estimated $45K sold.

Natixis Investment Managers International first reported a position in NVO in Q2 2017 and held it in 6 quarters. The position peaked at $45K in Q3 2018. 550 funds tracked by Wall St. Rank hold NVO as of Q4 2018.

  • Natixis Investment Managers International reported no remaining Novo Nordisk position as of Q4 2018 after selling out during the quarter.
  • Natixis Investment Managers International sold 1,926 Novo Nordisk shares in Q4 2018, an estimated $45K.
  • Natixis Investment Managers International first reported a position in Novo Nordisk in Q2 2017 and held it in 6 quarters.
  • Natixis Investment Managers International's Novo Nordisk position peaked at $45K in Q3 2018.
  • 550 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2018.

Based on Natixis Investment Managers International's 13F filing for Q4 2018, filed 14 Feb 2019.